TNFRSF8 and Hodgkins lymphoma: CD30 was originally defined as a marker of Hodgkin lymphomas [2, 3], but its expression was later also observed on the surface of other lymphomas, such as diffuse large B-cell lymphomas and primary effusion lymphomas [4–6], and on a subfraction of activated B and T cells.